Alogliptin: a new addition to the class of DPP-4 inhibitors

Marc Rendell
2009 Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy  
doi:10.2147/dmso.s4312 fatcat:rpwtvm4d7jcqrj4wucki5ex4xe